June 19, 2014 at 07:00PM Draft Guidance for Industry: Determining the Need for and Content of Environmental Assessments for Gene Therapies, Vectored Vaccines, and Related Recombinant Viral or Microbial Products

via What's New: Vaccines, Blood & Biologics RSS Feed http://ift.tt/UmTMf0